KOCAA
Knights of Columbus Asset Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,172
| Closed | -$186K | – | 406 |
|
|
2024
Q1 | $186K | Sell |
3,172
-3,021
| -49% | -$178K | 0.01% | 318 |
|
|
2023
Q4 | $371K | Sell |
6,193
-429
| -6% | -$25.7K | 0.02% | 288 |
|
|
2023
Q3 | $252K | Buy |
6,622
+170
| +3% | +$6.47K | 0.02% | 300 |
|
|
2023
Q2 | $588K | Sell |
6,452
-14,522
| -69% | -$1.32M | 0.05% | 268 |
|
|
2023
Q1 | $1.38M | Buy |
20,974
+2,283
| +12% | +$151K | 0.14% | 219 |
|
|
2022
Q4 | $967K | Sell |
18,691
-367
| -2% | -$19K | 0.1% | 227 |
|
|
2022
Q3 | $1.3M | Buy |
19,058
+2,319
| +14% | +$158K | 0.13% | 208 |
|
|
2022
Q2 | $757K | Buy |
16,739
+156
| +0.9% | +$7.06K | 0.08% | 234 |
|
|
2022
Q1 | $843K | Buy |
16,583
+110
| +0.7% | +$5.59K | 0.07% | 234 |
|
|
2021
Q4 | $779K | Buy |
16,473
+245
| +2% | +$11.6K | 0.06% | 232 |
|
|
2021
Q3 | $535K | Sell |
16,228
-6,150
| -27% | -$203K | 0.05% | 244 |
|
|
2021
Q2 | $1.41M | Buy |
22,378
+79
| +0.4% | +$4.99K | 0.13% | 220 |
|
|
2021
Q1 | $957K | Buy |
+22,299
| New | +$957K | 0.09% | 244 |
|